[1].Zhao X, Li X, Ren Q, Tian J, Chen J. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways. Gene591,123-128, (2016)
[2]. Lee JS, Kang JH, Boo HJ, Hwang SJ, Hong S, Lee SC,et al. STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody. Nat Commun 6,8499, (2015)
[3]. Wang Q, Lu W, Yin T, Lu L. Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells. J Exp Clin Cancer Res38,240 (2019)
[4].Yang K, Jiang B, Lu Y, Shu Q, Zhai P, Zhi Q, et al. FOXM1 promotes the growth and metastasis of colorectal cancer via activation of β-catenin signaling pathway. Cancer Manag Res 11,3779-3790 (2019).
[5].Yang H, Wen L, Wen M, Liu T, Zhao L, Wu B, et al. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. Anticancer Drugs 29,216-226 (2018).
[6].Wu Y, Brodt P, Sun H, Mejia W, Novosyadlyy R, Nunez N,et al. Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res70,57-67 (2010).
[7].Sanabria-Figueroa E, Donnelly SM, Foy KC, Buss MC, Castellino RC, Paplomata E,et al. Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1. Mol Pharmacol 87,150-161(2015).
[8].Laissue P. The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis. Mol Cancer 18, ( 2019)
[9].Yan D, Yan X, Dai X, Chen L, Sun L, Li T,et al. Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells. Oncol Rep 42,785-796 (2019).
[10].Kanemaru H, Yamane F, Tanaka H, Maeda K, Satoh T, Akira S. BATF2 activates DUSP2 gene expression and up-regulates NF-κB activity via phospho-STAT3 dephosphorylation. Int Immunol 30,255-265 (2018).
[11]. Yang H3, Li TW, Peng J, Mato JM, Lu SC. Insulin-like growth factor 1 activates methionine adenosyltransferase 2A transcription by multiple pathways in human colon cancer cells. Biochem J 436,507-516 (2011).
[12].Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T,et al. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 133,207-218 (2007).
[13].Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19,1752-1763(2000).
[14]. Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, Heger A, Hetherington K, Holm L, Mistry J, Sonnhammer EL, Tate J, Punta M. Pfam: the protein families database. Nucleic Acids Res 42,D222-230(2014).
[15].Chen J, Hou R, Zhang X, Ye Y, Wang Y, Tian J. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. PLoS One. 9,e91245(2014).
[16]. Chen J, Zhao X, Li X, Wu Y. Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells. Food Funct 6,3091-3097(2015).
[17]. Zhao X, Li X, Ren Q, Tian J, Chen J. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways. Gene591,123-128(2016).
[18].Ji Z, He L, Regev A, Struhl K. Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers. Proc Natl Acad Sci U S A 116,9453-9462(2019).
[19].Jiang XF, Ding L, Tian Y, Han N, Li ZQ. Interaction of STAT3 and RelB modulates MMP-1 in colon cancer. Chem Biol Interact 293,94-99(2018).
[20].Fan Y, Mao R, Yang J. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4,176-185(2013).
[21].Liao J, Humphrey SE, Poston S, Taparowsky EJ. Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells. Mol Cancer Res 9,350-363(2011).
[22]. Kanemaru H, Yamane F, Fukushima K, Matsuki T, Kawasaki T, Ebina I,et al. Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages. Proc Natl Acad Sci U S A114,E7331-E7340(2017).
[23].Dai L, Liu Y, Cheng L, Wang H, Lin Y, Shi G,et al. SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells. Mucosal Immunol 12,1130-1140(2019).
[24].De Simone V, Franzè E, Ronchetti G, Colantoni A, Fantini MC, et al.Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene 34,3493-3503(2015).
[25].Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res71,4329-4333(2011).
[26].Bach DH, Long NP, Luu TT, Anh NH, Kwon SW, Lee SK. The Dominant Role of Forkhead Box Proteins in Cancer. Int J Mol Sci19,3279(2018).
[27].Wang D, Hu G, Du Y, Zhang C, Lu Q, Lv N,et al. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells. J Exp Clin Cancer Res. 36,23(2017).
[28].Liu C, Shi J, Li Q, Li Z, Lou C, Zhao Q, et al.STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer. Clin Sci (Lond) 133,645-663(2019).
[29].Gartel AL. A new target for proteasome inhibitors: FoxM1. Expert Opin Investig Drugs19 ,235-42(2010).
[30].Jin B, Wang C, Li J, Du X, Ding K, Pan J. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia. Clin Cancer Res 23,789-803(2017).
[31].Senga T, Iwamoto T, Humphrey SE, Yokota T, Taparowsky EJ, Hamaguchi M. Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells. Oncogene 21,8186-8191(2002).
[32].Yang K, Jiang L, Hu Y, Yu J, Chen H, Yao Y,et al. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation. J Exp Clin Cancer Res 34,40(2015).
[33].Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H,et al. FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell20,427-442(2011).